Elenbecestat (E2609) is an Orally Active and CNS-penetrant BACE-1 Inhibitor
AAlzheimer's disease (AD) is a neurodegenerative disease, characterized by progressive memory loss. In AD patients' brain, the Aβ-containing plaques and tau-containing neurofibrillary tangles exhibit significant accumulation. Aβ is primarily generated…